Dr. Dan Schuller, M.D

NPI: 1467566042
Total Payments
$152,638
2024 Payments
$88.60
Companies
23
Transactions
267
Medicare Patients
721
Medicare Billing
$158,822

Payment Breakdown by Category

Other$135,420 (88.7%)
Travel$9,643 (6.3%)
Food & Beverage$5,193 (3.4%)
Consulting$2,275 (1.5%)
Education$107.49 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $135,420 60 88.7%
Travel and Lodging $9,643 70 6.3%
Food and Beverage $5,193 127 3.4%
Consulting Fee $2,275 6 1.5%
Education $107.49 4 0.1%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $55,928 89 $0 (2019)
PFIZER INC. $40,189 58 $0 (2018)
E.R. Squibb & Sons, L.L.C. $22,779 23 $0 (2018)
Janssen Pharmaceuticals, Inc $15,213 25 $0 (2018)
Boehringer Ingelheim Pharmaceuticals, Inc. $8,194 20 $0 (2021)
Bayer HealthCare Pharmaceuticals Inc. $6,313 6 $0 (2019)
Sunovion Pharmaceuticals Inc. $2,741 8 $0 (2017)
United Therapeutics Corporation $331.89 11 $0 (2024)
Genentech USA, Inc. $214.18 2 $0 (2018)
Merck Sharp & Dohme Corporation $168.49 6 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $88.60 1 United Therapeutics Corporation ($88.60)
2022 $277.25 7 United Therapeutics Corporation ($116.60)
2021 $198.00 2 Boehringer Ingelheim Pharmaceuticals, Inc. ($120.50)
2020 $11.37 1 Smith+Nephew, Inc. ($11.37)
2019 $12,682 19 Gilead Sciences, Inc. ($11,632)
2018 $48,295 77 Gilead Sciences, Inc. ($27,770)
2017 $91,087 160 PFIZER INC. ($30,019)

All Payment Transactions

267 individual payment records from CMS Open Payments — Page 1 of 11

Date Company Product Nature Form Amount Type
06/28/2024 United Therapeutics Corporation Food and Beverage In-kind items and services $88.60 General
10/14/2022 United Therapeutics Corporation ORENITRAM (Drug) Education In-kind items and services $2.50 General
Category: PAH
10/14/2022 United Therapeutics Corporation REMODULIN (Drug) Education In-kind items and services $2.50 General
Category: PAH
10/14/2022 United Therapeutics Corporation REMODULIN (Drug) Education In-kind items and services $2.50 General
Category: PAH
08/15/2022 United Therapeutics Corporation TYVASO (Drug), REMODULIN Food and Beverage In-kind items and services $9.07 General
Category: PAH
08/12/2022 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Education In-kind items and services $99.99 General
Category: Cardiology
06/13/2022 United Therapeutics Corporation Food and Beverage In-kind items and services $100.03 General
06/01/2022 Sobi, Inc DOPTELET (Drug) Food and Beverage In-kind items and services $60.66 General
Category: HEMATOLOGY/ONCOLOGY
09/14/2021 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $120.50 General
Category: RESPIRATORY
08/17/2021 Dova Pharmaceuticals Doptelet (Drug) Food and Beverage In-kind items and services $77.50 General
Category: Hematology/Oncology
12/21/2020 Smith+Nephew, Inc. GRAFIX PL (Biological) Food and Beverage In-kind items and services $11.37 General
Category: Other Advanced Wound Management
11/18/2019 Bayer HealthCare Pharmaceuticals Inc. Adempas (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,050.00 General
Category: Cardio-pulmonary
06/19/2019 Gilead Sciences, Inc. Travel and Lodging In-kind items and services $38.09 General
06/19/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $33.22 General
06/19/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $18.98 General
06/17/2019 Gilead Sciences, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,500.00 General
06/14/2019 Gilead Sciences, Inc. Travel and Lodging In-kind items and services $799.92 General
06/14/2019 Gilead Sciences, Inc. Travel and Lodging In-kind items and services $337.95 General
06/14/2019 Gilead Sciences, Inc. Travel and Lodging In-kind items and services $261.70 General
06/14/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $11.75 General
03/12/2019 Gilead Sciences, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,500.00 General
03/12/2019 Gilead Sciences, Inc. Travel and Lodging In-kind items and services $16.24 General
03/09/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $42.12 General
02/14/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $62.76 General
02/14/2019 Gilead Sciences, Inc. Travel and Lodging In-kind items and services $39.60 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 170 310 $97,204 $28,008
2022 5 157 310 $120,728 $33,031
2021 5 168 348 $152,482 $43,791
2020 5 226 430 $169,088 $53,992
Total Patients
721
Total Services
1,398
Medicare Billing
$158,822
Procedure Codes
23

All Medicare Procedures & Services

23 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 41 88 $27,808 $7,717 27.8%
99291 Critical care, first 30-74 minutes Facility 2023 15 45 $28,070 $7,340 26.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 28 77 $13,760 $4,663 33.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 20 20 $10,000 $2,656 26.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 18 18 $7,036 $2,191 31.1%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 15 21 $5,389 $1,914 35.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 11 12 $2,676 $826.20 30.9%
94618 Test for exercise-induced lung stress Office 2023 22 29 $2,465 $701.86 28.5%
99291 Critical care, first 30-74 minutes Facility 2022 34 87 $59,334 $14,504 24.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 38 74 $23,148 $6,949 30.0%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 46 76 $19,456 $5,868 30.2%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 21 55 $9,790 $2,985 30.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 18 18 $9,000 $2,725 30.3%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 49 156 $96,174 $26,543 27.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 58 115 $29,483 $9,069 30.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 26 41 $12,556 $3,846 30.6%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 23 23 $11,452 $3,510 30.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 12 13 $2,817 $823.19 29.2%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 64 173 $95,323 $30,706 32.2%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 74 144 $37,008 $11,945 32.3%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 43 44 $22,000 $6,952 31.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 26 41 $7,380 $2,372 32.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 19 28 $7,377 $2,017 27.3%

About Dr. Dan Schuller, M.D

Dr. Dan Schuller, M.D is a Pulmonary Disease healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467566042.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dan Schuller, M.D has received a total of $152,638 in payments from pharmaceutical and medical device companies, with $88.60 received in 2024. These payments were reported across 267 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($135,420).

As a Medicare-enrolled provider, Schuller has provided services to 721 Medicare beneficiaries, totaling 1,398 services with total Medicare billing of $158,822. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.

Practice Information

  • Specialty Pulmonary Disease
  • Other Specialties Critical Care Medicine
  • Location El Paso, TX
  • Active Since 08/19/2006
  • Last Updated 10/21/2024
  • Taxonomy Code 207RP1001X
  • Entity Type Individual
  • NPI Number 1467566042

Products in Payments

  • ELIQUIS (Drug) $62,944
  • Letairis (Drug) $17,899
  • XARELTO (Drug) $15,213
  • Adempas (Drug) $6,313
  • UTIBRON (Drug) $2,741
  • OFEV (Drug) $193.65
  • ZERBAXA (Drug) $152.91
  • Esbriet (Biological) $142.89
  • GIAPREZA (Drug) $103.44
  • OPSUMIT (Drug) $99.99
  • ORENITRAM (Drug) $78.00
  • Doptelet (Drug) $77.50
  • DOPTELET (Drug) $60.66
  • OFIRMEV (Drug) $58.49
  • REMODULIN (Drug) $36.64
  • STIOLTO (Drug) $29.53
  • TYVASO (Drug) $28.62
  • AVYCAZ (Drug) $24.91
  • CHANTIX (Drug) $23.92
  • Kcentra (Biological) $23.15

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pulmonary Disease Doctors in El Paso